Cerity Partners’s Integra LifeSciences IART Stock Holding History

Cerity Partners’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$393K	Buy	+21,896	New	+$306K	﹤0.01%	2592
2026 Q1	–	Sell	-15,622	Closed	-$194K	–	3317
2025 Q4	$194K	Sell	15,622 -883	-5%	-$11.7K	﹤0.01%	2645
2025 Q3	$237K	Buy	+16,505	New	+$226K	﹤0.01%	2418
2024 Q3	–	Sell	-13,949	Closed	-$406K	–	2570
2024 Q2	$406K	Buy	13,949 +5,416	+63%	+$161K	﹤0.01%	1646
2024 Q1	$302K	Buy	8,533 +1,841	+28%	+$73.6K	﹤0.01%	1863
2023 Q4	$291K	Buy	+6,692	New	+$263K	﹤0.01%	1533
2023 Q3	–	Sell	-10,755	Closed	-$442K	–	1538
2023 Q2	$442K	Buy	+10,755	New	+$518K	﹤0.01%	1232

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Cerity Partners's IART Position: Q2 2026 in Review

Cerity Partners opened a new position in Integra LifeSciences (IART) in Q2 2026: 21,896 shares worth $393K. The stake represents ﹤0.01% of the portfolio and ranks #2592 among its holdings. This is a return to the name: Cerity Partners previously reported a position in IART as recently as Q4 2025.

Cerity Partners first reported a position in IART in Q2 2023 and has held it in 7 quarters since. The position peaked at $442K in Q2 2023. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Cerity Partners held 21,896 shares of Integra LifeSciences worth $393K as of Q2 2026.
Integra LifeSciences was a new Cerity Partners position in Q2 2026.
Integra LifeSciences made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2592 holding.
Cerity Partners first reported a position in Integra LifeSciences in Q2 2023 and has held it in 7 quarters since.
Cerity Partners's Integra LifeSciences position peaked at $442K in Q2 2023.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.